Maintaining Supply Continuity: 3 Ways To Ease Pharma CMO And CDMO Worries

By James Jardine, MasterControl

Supply chain continuity has always been a pressing issue for contract manufacturing organizations (CMOs) and contract development manufacturing organizations (CDMOs) in the pharmaceutical industry. However, COVID-19’s enduring ripple effects indicate that the severity of supply continuity problems in the CMO contract manufacturing world is rising even as the pandemic appears to be waning.

Many supply issues are outside the control of pharma CMOs and CDMOs. But if supply continuity problems worsen, cautiously optimistic outsourcing organizations would be wise to find ways to exert greater control over the controllable aspects of their supply chains and general CMO manufacturing activities. These three practical steps will help pharma contract outsourcers exercise greater control over their supplier-related data, interactions, and processes and put them in a better position to cope with supply continuity challenges as they arise.